These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23969185)

  • 21. Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
    Pabalan N; Montagna E; Singian E; Tabangay L; Jarjanazi H; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2016; 39(6):2249-2261. PubMed ID: 27832628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
    Bungum L; Franssohn F; Bungum M; Humaidan P; Giwercman A
    PLoS One; 2013; 8(9):e68223. PubMed ID: 24023708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS).
    Zhong X; Jin F; Huang C; Du M; Gao M; Wei X
    Technol Health Care; 2021; 29(S1):11-25. PubMed ID: 33682741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Relationship between AMH and AMHR2 Polymorphisms and the Follicular Phase in Late Reproductive Stage Women.
    Jurczak A; Szkup M; Grzywacz A; Safranow K; Grochans E
    Int J Environ Res Public Health; 2016 Feb; 13(2):185. PubMed ID: 26848671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
    J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of anti-Müllerian hormone signaling pathway in healthy Singapore women: population differences, endocrine effects and reproductive outcomes.
    Yu ED; Zhu H; Li Y; Chua SE; Indran IR; Li J; Yong EL
    Gynecol Endocrinol; 2016; 32(4):311-4. PubMed ID: 26633196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial expression of anti-Müllerian hormone and its type II receptor in women with polycystic ovary syndrome.
    Paulson M; Sahlin L; Hirschberg AL
    Reprod Biomed Online; 2020 Jul; 41(1):128-137. PubMed ID: 32444258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles.
    Borgbo T; Jeppesen JV; Lindgren I; Lundberg Giwercman Y; Hansen LL; Yding Andersen C
    Mol Hum Reprod; 2015 Mar; 21(3):255-61. PubMed ID: 25403644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.
    Le MT; Le VNS; Le DD; Nguyen VQH; Chen C; Cao NT
    Clin Endocrinol (Oxf); 2019 Apr; 90(4):579-585. PubMed ID: 30636332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dominant negative mutation at the ATP binding domain of AMHR2 is associated with a defective anti-Müllerian hormone signaling pathway.
    Li L; Zhou X; Wang X; Wang J; Zhang W; Wang B; Cao Y; Kee K
    Mol Hum Reprod; 2016 Sep; 22(9):669-78. PubMed ID: 27430550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant anti-Müllerian hormone in the maturation medium improves the in vitro maturation of human immature (GV) oocytes after controlled ovarian hormonal stimulation.
    Bedenk J; Režen T; Železnik Ramuta T; Jančar N; Vrtačnik Bokal E; Geršak K; Virant Klun I
    Reprod Biol Endocrinol; 2022 Jan; 20(1):18. PubMed ID: 35073905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in the ACVR1 gene are associated with AMH levels in women with polycystic ovary syndrome.
    Kevenaar ME; Themmen AP; van Kerkwijk AJ; Valkenburg O; Uitterlinden AG; de Jong FH; Laven JS; Visser JA
    Hum Reprod; 2009 Jan; 24(1):241-9. PubMed ID: 18854405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometriosis-associated infertility: GDF-9, AMH, and AMHR2 genes polymorphisms.
    De Conto E; Matte Ú; Bilibio JP; Genro VK; Souza CA; Leão DP; Cunha-Filho JS
    J Assist Reprod Genet; 2017 Dec; 34(12):1667-1672. PubMed ID: 28831646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.